about
Neutrophil Responses to Sterile Implant MaterialsInjectable and Glucose-Responsive Hydrogels Based on Boronic Acid-Glucose ComplexationSmart approaches to glucose-responsive drug deliveryEnhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrixIn vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightSynergistic regulation of cerebellar Purkinje neuron development by laminin epitopes and collagen on an artificial hybrid matrix constructGlucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates.A bioactive self-assembled membrane to promote angiogenesis.Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivoA Peptide-Based Material for Therapeutic Carbon Monoxide DeliverySelf-assembly of amphiphilic tripeptides with sequence-dependent nanostructure.Photodynamic control of bioactivity in a nanofiber matrix.A perspective on the clinical translation of scaffolds for tissue engineeringInjectable Self-Healing Glucose-Responsive Hydrogels with pH-Regulated Mechanical PropertiesIn vivo compatibility of graphene oxide with differing oxidation statesCovalent Incorporation of Trehalose within Hydrogels for Enhanced Long-Term Functional Stability and Controlled Release of Biomacromolecules.Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature.Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.Supramolecular PEGylation of biopharmaceuticalsEfficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo.Drug delivery by supramolecular design.Supramolecular biomaterials.Materials for non-viral intracellular delivery of messenger RNA therapeutics.Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory responseUptake of calcium phosphate nanoshells by osteoblasts and their effect on growth and differentiation.Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primatesSelf-assembled hydrogels utilizing polymer-nanoparticle interactions.Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the LungsInjectable network biomaterials via molecular or colloidal self-assembly.A Facile and Versatile Method to Endow Biomaterial Devices with Zwitterionic Surface Coatings.Reprint of: Development of bioactive peptide amphiphiles for therapeutic cell delivery.Rapid vascularization of starch-poly(caprolactone) in vivo by outgrowth endothelial cells in co-culture with primary osteoblastsScaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cellsFine-tuning scaffolds for tissue regeneration: effects of formic acid processing on tissue reaction to silk fibroinDynamic Hydrogels from Host-Guest Supramolecular InteractionsGrowth factor release from a chemically modified elastomeric poly(1,8-octanediol-co-citrate) thin film promotes angiogenesis in vivoEvaluation of the tissue reaction to a new bilayered collagen matrix in vivo and its translation to the clinicNovel four-disulfide insulin analog with high aggregation stability and potency
P50
Q27318618-C3AAD457-37D1-42F6-96DA-BC579DB9DE25Q28468535-88AF67FF-4A84-4DDA-85FA-65493DE9045FQ33742934-BC547A13-8E2E-4115-BE04-D9C5865B28CEQ34055868-35E694A1-D9E8-4831-924F-B4DC59DCA1F5Q34393539-D0BC4AE4-AB8A-4B5D-B174-B0CA31F645D3Q34722418-BB2B4405-41E7-452F-9256-1508440B15AFQ35134731-41CBD93A-5517-4CF7-A3EE-1AD79BCCF43AQ35148242-96D7EF39-F763-4123-9BFD-D05E278CBD20Q35374908-EF194BF2-B588-450C-A914-018B8FB4BA3BQ36030131-7666266D-6C0B-4DB8-94F2-248EDFE01972Q36375055-14D9BA45-E7DD-4BF8-83B4-9018DC908A70Q36484516-0E7FADB8-4833-4FE3-96F7-DA7A4B0E200BQ36671386-36518C75-8109-4409-949D-C2358658C391Q36779220-11713701-9039-4A8E-B697-86100C948C6DQ36779229-B83DAE01-18CE-442C-B1CA-A4F90ADDAD8BQ36781510-42ED59C2-FEEF-498D-835E-CCA7CEB41855Q36781516-4F8F2D08-3A6E-4DF5-B42C-2E2FA0BFB0ADQ37207691-FF69A2C4-BFFC-495A-866A-C33922E0DA3AQ37283351-6048DEC2-D7C6-4136-AC37-D316B77FAFA5Q37515001-018693E1-C34E-47FE-9E64-4A74B86F0C72Q37607987-8FC1F700-062C-4ADF-B441-44152173AC23Q37613212-FAF16AF5-C509-4802-A174-DD604A5C1750Q38638945-8AB7CE57-2889-45D0-A0AA-9D6C4867D15FQ38673121-36EE6AA2-471B-4B15-9BEC-7CC66F756EE3Q38683527-978160DA-D1A9-474A-B942-375A99C1D9F8Q39322467-B04ED49D-C742-4D65-96D0-510F1D03FACEQ40026770-0CD51D2A-3D42-4A65-B5A7-10B676D505C7Q41716521-A26FC4A4-CF9F-45AE-8897-2CCE570C59AAQ41881569-D46E5C85-7BAE-4B66-A960-756C61FA4D9BQ41961592-54899029-5A3B-40C0-81A9-1CE669232D24Q47358252-F92AD99D-62C3-4B9C-BB10-F60EADE3F82EQ51079293-E17A29BC-382F-4C0D-9D86-F796B3725562Q51824321-5E9C8957-33C6-4411-B661-725818135D52Q57170555-44012D30-3388-4EED-90B3-4948D12D9952Q57218387-B45B0627-C61C-4754-946F-71F7857AE3A5Q57219033-15969B87-D3F9-4E35-9934-7BCE69E254A6Q57285223-1BE8AC00-80EA-4109-A2F9-EE9B7BFA8ACCQ82916774-4C49E176-BEA3-4FD1-B2DB-A889B38E00E3Q83217451-439ABA61-BC6B-453A-AAE8-4DA126A9C2B4Q89941132-F64A13CA-0888-43E5-B837-D24680B314DB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Matthew J Webber
@nl
Matthew J Webber
@sl
Matthew J. Webber
@en
Matthew J. Webber
@es
type
label
Matthew J Webber
@nl
Matthew J Webber
@sl
Matthew J. Webber
@en
Matthew J. Webber
@es
prefLabel
Matthew J Webber
@nl
Matthew J Webber
@sl
Matthew J. Webber
@en
Matthew J. Webber
@es
P106
P1153
26633186400
56912936900
P31
P496
0000-0003-3111-6228